captopril has been researched along with interleukin-8 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Center, DM; Danilov, SM; Farber, HW; Rounds, S | 1 |
| Chichorro, JG; Lorenzetti, BB; Zampronio, AR | 1 |
| Asadikaram, G; Ebrahimi, N; Kazemi Arababadi, M; Kiani, Z; Kohan, F; Masoumi, M; Nasiri, AA; Sepehri, Z; Sheikh Fathollahi, M | 1 |
| Azab, SS; El-Demerdash, E; Mantawy, EM; Mostafa, F | 1 |
4 other study(ies) available for captopril and interleukin-8
| Article | Year |
|---|---|
Components of the angiotensin system cause release of a neutrophil chemoattractant from cultured bovine and human endothelial cells.
Topics: Angiotensin I; Angiotensin II; Animals; Aorta; Bradykinin; Captopril; Cattle; Cells, Cultured; Chemotactic Factors; Chemotaxis, Leukocyte; Chromatography, High Pressure Liquid; Endothelium, Vascular; Humans; In Vitro Techniques; Interleukin-8; Neutrophils; Pulmonary Artery; Renin-Angiotensin System; Saralasin; Umbilical Veins | 1990 |
Involvement of bradykinin, cytokines, sympathetic amines and prostaglandins in formalin-induced orofacial nociception in rats.
Topics: Animals; Arachidonic Acids; Atenolol; Behavior, Animal; Biogenic Amines; Bradykinin; Bradykinin B1 Receptor Antagonists; Bradykinin B2 Receptor Antagonists; Captopril; Celecoxib; Cytokines; Dose-Response Relationship, Drug; Drug Synergism; Facial Pain; Formaldehyde; Guanethidine; Hindlimb; Indomethacin; Injections, Subcutaneous; Interleukin-6; Interleukin-8; Lip; Male; Meloxicam; Nociceptors; Prostaglandins; Pyrazoles; Rats; Rats, Wistar; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Sulfonamides; Thiazines; Thiazoles; Tumor Necrosis Factor-alpha; Tyramine | 2004 |
Atorvastatin, Losartan and Captopril Lead to Upregulation of TGF-β, and Downregulation of IL-6 in Coronary Artery Disease and Hypertension.
Topics: Antihypertensive Agents; Atorvastatin; Captopril; Coronary Artery Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Inflammation; Interleukin-6; Interleukin-8; Iran; Losartan; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Up-Regulation | 2016 |
The angiotensin converting enzyme inhibitor captopril attenuates testosterone-induced benign prostatic hyperplasia in rats; a mechanistic approach.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Fibroblast Growth Factor 2; Gene Expression Regulation; Interleukin-8; Male; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Testosterone; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2019 |